USA - Equities (7.12%, 2010: 
 7.90%) 
 Bionostics Holdings Limited           3,000,000    1,310,077             2.34 
 Bionostics Holdings Limited 
  Preference Shares                    3,000,000      935,769             1.67 
 EOriginal Inc Series B Shares            12,513            -                - 
 Nastor Investments Limited 
  Preference Shares                    2,284,752    1,425,334             2.55 
 Tagos                                   500,000      311,923             0.56 
                                                  -----------  --------------- 
                                                    3,983,103             7.12 
 USA - Warrants (Nil 2010: Nil) 
 EOriginal Inc Warrants                      562            -                - 
 ICarbon Corp Warrants                   245,092            -                - 
                                                  -----------  --------------- 
                                                            -                - 
 
 Total unlisted investments                         9,518,017            17.03 
                                                  -----------  --------------- 
 
 
 
 Total investments    54,466,584    97.47 
                     -----------  ------- 
 
 Cash                    880,745     1.57 
 
 Other net assets        534,566     0.96 
 
 Total net assets     55,881,895   100.00 
                     -----------  ------- 
 

DIRECTORS' REPORT

The Directors are pleased to present their Report and consolidated Financial Statements of the Company for the year ended 31 March 2011.

Business review

A review of the Company's activities is given in the Corporate Summary on page 2, the Chairman's statement on page 4 and the Investment Adviser's report on page 5. This includes a review of the business of the Company and its principal activities, likely future developments of the business, dividends policy and details of the buyback of shares for cancellation during the year by the Company. The Company's investment policy and its approach to achieving the investment policy and managing the associated risks are set out below and in note 19 to the Consolidated Financial Statements. The Key Performance Indicators for the Company including NAV performance, share price performance and benchmark performance are contained within the Chairman's statement and the Investment Adviser's report.

The current Directors, Messrs N Cayzer, S Cabessa, W Chatila, R Evans, C Hannaway (resigned on 31(st) December 2010), C Mills, J Radziwill and J Grace (appointed on 8(th) March 2011) were the only Directors in office during the year.

The Company does not make political donations or expenditures and has not made any donations for charitable purposes during the year and in common with other investment funds, the Company has no employees. Directors' and Officers' liability insurance cover has been maintained throughout the year at the expense of the Company.

Investment policy

The Company principally invests in small and mid-size quoted and unquoted companies in the United Kingdom and United States. The Investment Manager targets companies that have fundamentally strong business models but where there may be specific factors which are constraining the maximisation or realisation of shareholder value, which may be realised through the pursuit of an activist shareholder agenda by the Investment Manager. Dividend income is a secondary consideration when making investment decisions.

Achieving the Investment Policy

The investment approach of the Investment Manager is characterised by a rigorous focus on research and financial analysis of potential investee companies so that a thorough understanding of their business models is gained prior to investment. Comprehensive due diligence, including one or more meetings with management as well as site visits, are standard procedure before shares are acquired.

Typically the portfolio will comprise of 40 to 60 holdings (but without restricting the Company from holding a more or less concentrated portfolio in the future).

The Company may invest in derivatives, financial instruments, money market instruments and currencies solely for the purpose of efficient portfolio management (i.e. solely for the purpose of reducing, transferring or eliminating investment risk in the Company's investments, including any technique or instrument used to provide protection against exchange and credit risks).

The Investment Manager expects the Company's assets will normally be fully invested. However, during periods in which changes in economic conditions or other factors so warrant, the Company may reduce its exposure to securities and increase its position in cash and money market instruments.

A detailed description of the investment process and risk controls employed by the Manager is disclosed in Note 19 to the consolidated financial statements. A comprehensive analysis of the Company's portfolio is disclosed on pages 5 to 9 including a description of the ten largest equity investments. At the year end the Company's portfolio consisted of 55 holdings. The top 10 holdings represented 59.58% of total net assets.

The Board is responsible for determining the gearing strategy for the Company. Gearing is used selectively to leverage the Company's portfolio in order to enhance returns where and to the extent this is considered

appropriate to do so. Borrowings are short term and particular care is taken to ensure that any bank covenants

permit maximum flexibility of investment policy.

The Company may only make material changes to its investment policies with the approval of Shareholders (in the form of an ordinary resolution).

Investment Restrictions

The Company has adopted the following policies:

(a) it will not invest in securities carrying unlimited liability;

(b) short selling for the purpose of efficient portfolio management will be permitted provided that the aggregate value of the securities subject to a contract for sale that has not been settled and which are not owned by the Company shall not exceed 20 per cent. of the Net Asset Value; in addition, the Company may engage in uncollateralised stock lending on normal commercial terms with counterparties whose ordinary business includes uncollateralised stock lending provided that the aggregate exposure of the Company to any single counterparty shall not exceed 20 per cent. of the Net Asset Value;

(c) it will not take legal or management control of investments in its portfolio;

(d) it will not buy or sell commodities or commodity contracts or real estate or interests in real estate although it may purchase and sell securities which are secured by real estate or commodities and securities of companies which invest in or deal in real estate commodities;

(e) it will not invest or lend more than 20 per cent of its assets in securities of any one company or single issuer;

(f) it will not invest more than 35 per cent of its assets in securities not listed or quoted on any

recognised stock exchange;

(g) it will not invest in any company where the investment would result in the company holding more than 10 per cent. of the issued share capital of that company or any class of that share capital, unless that company constitutes a trading company (for the purposes or the relevant United Kingdom legislation) in which case the company may not make any investment that would result in its holding 50 per cent. or more of the issued share capital of that company or of any class of that share capital;

(h) it will not invest more than 5 per cent. of its assets in units of unit trusts or shares or other forms of participation in managed open-ended investment vehicles;

(i) the Company may use options, foreign exchange transactions on the forward market, futures and contracts for differences for the purpose of efficient portfolio management provided that:

(1) in the case of options, this is done on a covered basis;

(2) in the case of futures and forward foreign exchange transactions, the face value of all such contracts does not exceed 100 per cent. of the Net Asset Value of the Company; or

(3) in the case of contracts for difference (including stock index future or options) the face value of all such contracts does not exceed 100 per cent. of Net Asset Value of the Company. None of these restrictions, however, require the realisation of any assets of the Company where any restriction is breached as a result of an event outside the control of the Investment Manager which occurs after the investment is made, but no further relevant assets may be acquired by the Company until the relevant restriction can again be complied with. In the event of any breach of these investment restrictions, the Board will as soon as practicable make an announcement on a Regulatory Information Service and subsequently write to Shareholders if appropriate; and

(j) the Company will ensure gearing does not exceed 20% of net assets.

CORPORATE GOVERNANCE

Introduction

The Board is accountable to shareholders for the governance of the company's affairs. Paragraph 9.8.6 of the UK Listing Rules requires all listed companies to disclose how they have applied the principles and complied with the provisions of the 2008 Combined Code. As an investment company, most of the Company's day-to-day responsibilities are delegated to third parties, the Company has no employees and the Directors are all non-executive. Therefore, not all of the provisions of the 2008 Combined Code are directly applicable to the Company.

The Directors believe that during the year under review they have complied with the provisions of the Combined Code, insofar as they apply to the Company's business.

In May 2010, the FRC published the new UK Corporate Governance Code which applies to accounting periods commencing on or after 29(th) June 2010 and will therefore be applicable to the Company for the year ended 31(st) March 2012.

Going Concern

Oryx International Growth (LSE:OIG)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024 Haga Click aquí para más Gráficas Oryx International Growth.
Oryx International Growth (LSE:OIG)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024 Haga Click aquí para más Gráficas Oryx International Growth.